Granulocyte macrophage colony-stimulating factor in the TME activated the JAK-STAT3 pathway to upregulate PD-L1 in neutrophils, thus promoting tumor-related immunosuppression and progression [195]. The gene discussed is STAT3; the disease is neoplasm.